Overview

Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors

Status:
RECRUITING
Trial end date:
2026-07-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of FCN-159 in patients with specific NF2-associated nerve sheath tumors.
Phase:
PHASE2
Details
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences